Four biotech visionaries from Europe, America, and Asia gathered to explore how AI and genomics are rewriting the rules of clinical design and drug innovation:

Manuel Sanz (Founder, ONCOMATRYX): Introduced OMTX705, an ADC turning "cold tumors" into "hot tumors", and highlighted how regulatory pressure is reshaping collaboration models.
David Flores (Founder, BioCentury): Revealed that Asia's newCO deals hit 188+, with regional innovation fast-tracking into the global scene—speed is the new edge.
Nick Meadows (Pharma Lead, PwC Australia): Emphasized integrating genomic data with lifetime health records. UK’s full-genome newborn sequencing is setting a global standard.
Rostina Yoon (VP, Syneos Health): Showcased GenAI in clinical trial optimization, declaring: “The age of guessing is over.” AI now drives precise, data-powered clinical planning.

From translational medicine to global capital flow to AI-powered trials, this forum proves: Asia is shaping the future of global biotech.

Full recap: https://reurl.cc/1OZYEp

#Globalbio #BIOAsiaTaiwan #AIinBiotech #GenAI #ADC #ClinicalInnovation #PrecisionMedicine #BiotechLeadership